Follicle centre lymphoma follicular grade I II III recurrent

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
0 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (tumor, humanized) 1 substance
Phase II: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase II

1 trial
  • Oslo University Hospital HF Academic
    MOSUNETUZUMAB
    2022-500100-21-01 4 countries 2023 n=80
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Oslo University Hospital HF Academic 1 Phase II 0
New trials by year
2023
1
← All indication landscapes